Healthcare Services

DNA Testing Market Analysis Reflecting Expansion Trends And Industry Performance

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The DNA Testing Market During The Forecast Period?

The dna testing market has experienced significant expansion recently. This market is projected to grow from $20.04 billion in 2025 to $22.4 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.8%. Historically, this expansion has been driven by factors such as advancements in molecular diagnostics, increased demand for infectious disease testing, wider adoption of cancer screening, the rise of laboratory automation, and greater funding for genetic research.

The dna testing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $32.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.9%. Key drivers for this growth during the forecast period include the integration of precision medicine, AI-based genetic interpretation, the emergence of population screening programs, the expansion of clinical genomics, and enhanced regulatory support for molecular diagnostics. Significant trends expected over the forecast period encompass the broader application of dna testing in clinical diagnostics, its increasing utilization in prenatal and newborn screening, growing acceptance in oncology and pharmacogenomics, the integration of automated testing platforms, and a heightened demand for personalized genetic insights.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp

Which Core Factors Are Supporting The Expansion Of The DNA Testing Market?

The escalating presence of genetic conditions is poised to stimulate the growth of the DNA testing market in the foreseeable future. These genetic conditions are medical ailments caused by irregularities in an individual’s DNA, resulting in physical, developmental, or functional impairments. The increasing frequency of genetic disorders is propelled by expanded genetic screening, enhanced diagnostic capabilities, heightened public awareness, and the continued prevalence of consanguineous marriages in certain communities. The DNA testing market serves this demand by enabling prompt and accurate diagnosis, evaluating prognosis, creating personalized treatment strategies, and supporting informed family-planning decisions rooted in an individual’s genetic profile. For instance, in February 2023, the World Health Organization (WHO) reported that congenital diseases were estimated to cause 240,000 newborn deaths globally within the first 28 days of life annually. Additionally, according to the Centers for Disease Control and Prevention (CDC), around 6,000 babies are born with Down syndrome each year in the United States, representing 1 in every 700 births. Therefore, the expanding prevalence of genetic disorders is a key driver for the growth of the DNA testing market.

Which Segment-Based Categories Are Covered In The DNA Testing Market?

The dna testing market covered in this report is segmented –

1) By Product Type: Equipment, Consumables, Software And Services

2) By Technology: Polymerase Chain Reaction (PCR) Based, In-Situ Hybridization, Microarray, Next-Generation Sequencing (NGS) DNA Diagnosis

3) By Application: Newborn DNA Screening, Pre-Natal DNA Carrier Screening, Oncology Diagnostics And Histopathology, Pre-implantation Diagnosis, Infectious Disease Diagnostics, Pharmacogenomics Diagnostic Testing, Identify Diagnostics And Forensic, Other Applications

Subsegments:

1) By Equipment: PCR (Polymerase Chain Reaction) Machines, Sequencing Instruments, Microarray Systems, Electrophoresis Equipment

2) By Consumables: PCR Reagents, Sequencing Reagents, Hybridization Reagents, Enzymes And Buffers

3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Services, Consulting And Technical Support

Which Trends Are Affecting The DNA Testing Market Framework?

Companies operating in the DNA testing market are increasingly concentrating on developing sophisticated testing solutions, such as precancer detection DNA tests, to enhance early diagnosis, facilitate prompt intervention, and improve patient outcomes within cancer care. Precancer detection DNA tests are molecular diagnostic assays designed to identify initial genetic or epigenetic modifications, like mutations or methylation patterns, that are linked to the nascent stages of cancer development, thereby allowing medical professionals to detect the disease before symptoms appear. For instance, in November 2023, Lucid Diagnostics Inc., a US-based company focused on esophageal cancer prevention diagnostics, introduced EsoGuard 2.0. This next-generation esophageal DNA test delivers better assay performance and reduced expenses through its improved molecular techniques and higher DNA yield. The test utilizes the EsoCheck Cell Collection Device to analyze esophageal cell DNA via bisulfite conversion, PCR amplification, and next-generation sequencing, aiming to detect gene-specific methylation changes associated with esophageal precancer and cancer, thereby furnishing clinicians with a robust instrument for early detection and cancer prevention.

Who Are The Companies Shaping The DNA Testing Market Landscape?

Major companies operating in the dna testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc, Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc, Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd, Biocartis SA, CENTOGENE N.V., Everlywell Inc, Atlas Biomed Group Limited, Veritas Genetics

Access The Complete DNA Testing Market Report:

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Which Region Commands The Largest Share Of The DNA Testing Market?

North America was the largest region in the DNA testing market in 2025. The regions covered in the dna testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access DNA Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15358&type=smp

Browse Through More Reports Similar to the Global DNA Testing Market 2026, By The Business Research Company

Dna Test Kits Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-test-kits-global-market-report

Dna Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Genetic Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795